Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

PortugalBack to Portugal

Clinical trials in Castelo Branco

2 clinical trials in Castelo Branco, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Castelo Branco at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Castelo Branco

Open in trial search

Conjunctivitis allergic+1

Recruiting
Investigational
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dactylis Glomerata Pollen Extract
  • Sponsor:LETI Pharma S.L.U.

Conjunctivitis allergic+1

Recruiting
Investigational
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dactylis Glomerata Pollen Extract
  • Sponsor:LETI Pharma S.L.U.

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Castelo Branco

What the registry says about research in the country

01 Castelo Branco
Immune System Diseases
Clinical research in Castelo Branco is concentrating on immune system diseases, specifically allergic rhinoconjunctivitis with or without asthma triggered by grass and olive pollen. The studies evaluate the therapeutic benefit of allergen immunotherapy using a mobile symptom‑medication score to compare active treatment against placebo. Grass and olive allergen immunotherapy administered over multiple injections Use of a mobile application to capture combined symptom and medication scores Placebo‑controlled, double‑blind design to assess clinical efficacy Evaluation of treatment impact during peak pollen seasons Findings aim to confirm that targeted immunotherapy can reduce allergy burden and improve quality of life for patients with seasonal respiratory allergies.
Respiratory Tract Diseases
The respiratory tract diseases portfolio in Castelo Branco focuses on allergic rhinitis and controlled asthma associated with grass pollen exposure. Trials measure how allergen immunotherapy modifies airway reactivity and medication use, employing both double‑blind and open‑label phases to capture comprehensive efficacy data. Assessment of clinical efficacy of grass allergen immunotherapy across concentrations Change in allergen dose required for a positive challenge test after treatment Combined symptom‑medication score collected via mobile app during pollen peaks Comparison of active therapy with placebo to determine treatment benefit The goal is to demonstrate that immunotherapy can sustainably lessen respiratory symptoms and reduce reliance on rescue medication for individuals with seasonal allergies.
Back to PortugalAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.